This invention relates to substituted bicyclic dihydropyrimidinones of formula 1
and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.
本发明涉及式 1 的取代双环二氢
嘧啶酮
及其作为中性粒细胞
弹性蛋白酶活性
抑制剂的用途、含有该物质的药物组合物,以及使用该物质作为治疗和/或预防肺部、胃肠道和泌尿生殖系统疾病、皮肤和眼部炎症性疾病及其他自身免疫性和过敏性疾病、异体移植排斥反应和肿瘤疾病的药物的方法。